By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – UK-based Informatics firm Dotmatics said today that drug maker Pharmaxis will use its data-mining platform to manage its preclinical research data.

Dotmatics' Browser is an interactive dashboard for integrating and viewing research data from disparate sources, and its Vortex application offers predictive analytics, and data visualization and analysis applications.

Financial terms of the agreement were not released.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.